Tumor Virology, Immunology & Cellular Pathology

Oncogenes, tumour suppressors, oncogenic cofactors, disruption of innate and adaptive immune responses, latency, viral mimicry/piracy of cellular regulatory genes, genomic instability, and the function of non-coding RNAs in viral pathogenesis are all topics covered by tumour virology. The goal of this study is to advance vaccine techniques for the treatment of cancers associated with viral infections as well as viral vectors for human cancer gene therapy.

The most well-known application of cancer immunology is cancer immunotherapy, which makes use of the immune system as a cancer treatment. Cancer immunology is an interdisciplinary area of biology that focuses on understanding the role of the immune system in the development and progression of cancer.

The field of pathology known as cytopathology focuses on studying and diagnosing diseases at the cellular level. In 1928, George Nicolas Papanicolaou established the field. In contrast to histopathology, which examines complete tissues, cytopathology typically examines samples of free cells or fragments of tissue.

 

    Related Conference of Tumor Virology, Immunology & Cellular Pathology

    November 22-23, 2024

    4th International Conference on Medical Research and Development

    Aix-en-Provence, France
    November 25-26, 2024

    10th World Congress on Anesthesia and Critical Care

    Paris, France
    April 16-17, 2025

    9th International Conference on Internal Medicine

    Berlin, Germany
    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 16-17, 2025

    11th World Congress on Medicinal Plants and Marine Drugs

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France

    Tumor Virology, Immunology & Cellular Pathology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in